Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12134654 Multispecific molecules and uses thereof

Patent 12134654 was granted and assigned to Marengo Therapeutics on November, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Current Assignee

Marengo Therapeutics

Date Filed

April 19, 2018

Date of Patent

November 5, 2024

Patent Applicant

Marengo Therapeutics

Patent Application Number

16605936

Patent Citations

‌

US Patent 8552156 Anti-TIM-3 antibody

‌

US Patent 8609089 Compositions of PD-1 antagonists and methods of use

‌

US Patent 9522196 Antibody recognizing folate receptors α and β

‌

US Patent 9068002 Treatment of multiple sclerosis and/or rheumatoid arthritis

‌

US Patent 7476724 Humanized anti-cmet antibodies

‌

US Patent 7501121 IL-13 binding agents

‌

US Patent 7943743 Human monoclonal antibodies to programmed death ligand 1 (PD-L1)

‌

US Patent 8008449 Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics

‌

US Patent 8354509 Antibodies to human programmed death receptor PD-1

Patent Inventor Names

Stephanie J. Maiocco

Brian Edward Vash

Andreas Loew

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

12134654

Patent Primary Examiner

CPC Code

•••

Find more entities like US Patent 12134654 Multispecific molecules and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.